PULMOZYME 2500 U/2.5 ml, solution for inhalation by nebulizer 30 ampoules of 2.5 ml
Active ingredients: DÉSOXYRIBONUCLÉASE
Commercialized according to BDPMDispensing in France: Prescription only
Solution for inhalation by nebulizer30 ampoules of 2.5 mlinhalée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PULMOZYME 2500 U/2,5 ml, solution pour inhalation par nébuliseur
- Pharmaceutical form
- solution pour inhalation par nébuliseur
- Route of administration
- inhalée
- Presentation description
- 30 ampoule(s) polyéthylène de 2,5 ml
- Marketing authorisation holder
- CRISTERS
- Reimbursement according to BDPM
- 30 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 4 Oct 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63385292CIP74900566CIP133400949005666Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DÉSOXYRIBONUCLÉASEsolution | 2500 U (2,5 mg) · 2,5 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.